Literature DB >> 26912049

[Congenital nasolacrimal duct obstruction from an ophthalmologist's point of view : Causes, diagnosis and staged therapeutic concept].

J Heichel1, T Bredehorn-Mayr2, H-G Struck2.   

Abstract

BACKGROUND: Congenital nasolacrimal duct obstruction (CNLDO) is one of the most frequent issues in pediatric ophthalmology. There are different therapeutic options, including conservative treatments as well as surgical interventions. These strategies can be classified using a staged therapeutic concept.
OBJECTIVE: What are the therapeutic strategies for CNLDO from an ophthalmologist's point of view?
METHODS: In this review, different kinds of CNLDO are described. Existing therapeutic interventions are dedicated to the different forms of CNLDO and summarized in a staged therapeutic concept.
RESULTS: CNLDO is not a homogeneous disease. Different and also combined pathologies exist. According to symptoms and localization of stenosis, different therapeutic interventions are available. The most common CNLDO manifestation is a persistent Hasner's membrane. If conservative approaches have failed, pressurized probing and syringing of the nasolacrimal duct is the method of choice. This can usually be done under local anesthesia. Since some children show persisting symptoms, other therapies (probing and syringing under general anesthesia with nasolacrimal duct intubation, external dacryocystorhinostomy) have to be considered. Here, dacryoendoscopy offers additional diagnostic and therapeutic options.
CONCLUSION: The precise classification of CNLDO and knowledge concerning possible therapeutic interventions are essential. Due to ongoing development of surgical approaches, an increasingly individualized therapy is possible. A gradual therapeutic regimen is available for CNLDO, which has to be adapted individually.

Entities:  

Keywords:  Child; Dacryocystorhinostomy; Lacrimal apparatus; Lacrimal duct obstruction; Ophthalmology

Mesh:

Year:  2016        PMID: 26912049     DOI: 10.1007/s00106-016-0124-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  19 in total

1.  [Interdisciplinary endoscopic outpatient management of connatal dacryocystoceles].

Authors:  W Hosemann; B Lorenz; T Kühnel; S Leder
Journal:  Laryngorhinootologie       Date:  2002-04       Impact factor: 1.057

2.  Epiphora during the first year of life.

Authors:  C J MacEwen; J D Young
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

3.  Congenital impatency of the nasolacrimal duct.

Authors:  D GUERRY; E L KENDIG
Journal:  Arch Ophthal       Date:  1948-02

4.  [Treatment of congenital lacrimal duct obstruction: A prospective clinical cohort study].

Authors:  J Heichel; F Bachner; A Schmidt-Pokrzywniak; H-G Struck; U Stuhlträger; T Bredehorn-Mayr
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

5.  High prevalence of amblyopia risk factors in preverbal children with nasolacrimal duct obstruction.

Authors:  Noelle S Matta; David I Silbert
Journal:  J AAPOS       Date:  2011-08       Impact factor: 1.220

6.  Outcome of probing for congenital nasolacrimal duct obstruction in older children.

Authors:  S G Honavar; V E Prakash; G N Rao
Journal:  Am J Ophthalmol       Date:  2000-07       Impact factor: 5.258

7.  Orbital cellulitis and preseptal cellulitis in childhood.

Authors:  M Lawless; F Martin
Journal:  Aust N Z J Ophthalmol       Date:  1986-08

8.  Anisometropia and amblyopia in nasolacrimal duct obstruction.

Authors:  Michael A Kipp; Michael A Kipp; William Struthers
Journal:  J AAPOS       Date:  2013-04-18       Impact factor: 1.220

Review 9.  Management of congenital nasolacrimal duct obstruction.

Authors:  Yasuhiro Takahashi; Hirohiko Kakizaki; Weng O Chan; Dinesh Selva
Journal:  Acta Ophthalmol       Date:  2009-07-21       Impact factor: 3.761

10.  Success rates of nasolacrimal duct probing at time intervals after 1 year of age.

Authors:  R M Robb
Journal:  Ophthalmology       Date:  1998-07       Impact factor: 12.079

View more
  3 in total

Review 1.  [Minimally invasive diagnostics and therapy of congenital nasolacrimal duct obstruction].

Authors:  J Heichel; H-G Struck
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

2.  [Pediatric acute dacryocystitis due to frontoethmoidal mucocele].

Authors:  J Heichel; H-G Struck; T Hammer; A Viestenz; S Plontke; A Glien
Journal:  HNO       Date:  2019-06       Impact factor: 1.284

Review 3.  [Recognition and prevention of problems in lacrimal duct surgery].

Authors:  T Kühnel
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.